Hilary W. Heuer

Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf et al. · Nature Medicine · 2020 · 767 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +13

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom et al. · The Lancet Neurology · 2021 · 538 citations · Full text

Frontotemporal Lobar Degeneration, Neurodegenerative Diseases, Alzheimer's Disease +14

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman et al. · The Lancet Neurology · 2019 · 296 citations · Full text

Disease Duration, Neurodegenerative Diseases, Alzheimer's Disease +15

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

Adam L. Boxer, Anthony E. Lang, Murray Grossman et al. · The Lancet Neurology · 2014 · 282 citations · Full text

Placebo-controlled Phase 2/3, Progressive Supranuclear Palsy, Rehabilitation +3

Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic

Todd Logan, Matthew Simon, Gerald Maxwell Cherf et al. · Cell · 2021 · 210 citations · Full text

Neurodegenerative Diseases, Molecular Neuroscience, Lysosomal Storage Disorder +11